Cardinal Health Inc.
Cardinal Health Updates Long-Term Value Creation Plans and Financial Outlook
Summary
Cardinal Health, Inc. has updated its financial outlook and long-term targets. The company raised its FY25 non-GAAP diluted EPS guidance to $8.15 to $8.20 and established preliminary FY26 non-GAAP diluted EPS guidance of $9.10 to $9.30. Cardinal Health also confirmed its long-term target of 12% to 14% non-GAAP diluted EPS CAGR for FY26 to FY28. Furthermore, the company raised its long-term target for Pharmaceutical and Specialty Solutions profit to 5% to 7% normalized growth and for Other profit to ~10% normalized growth. The company also updated its GMPD long-term target to $50M+ of profit growth per year after FY26 and expects at least $10B in total adjusted free cash flow over the next three years. Additionally, Cardinal Health raised its baseline share repurchase plans to at least $750M per year. The company reiterated its strategic priorities and provided updates across its businesses.
Profitelligence Alerts
Get alerts for CAH
Be first to know when Cardinal Health Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Cardinal Health Inc.
Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.
Official SEC Documents
Advertisement